Reference basis
Curated clinical guidance, localization methods, device resources and safety references support the tools. Adaptations are identified within each tool.
Sources and guidance →
CTDSPurpose, development and evaluation
About CTDS
A connected workspace for clinician-led TMS assessment, placement and follow-up.
Why CTDS was developed
CTDS brings assessment, scalp localization, motor threshold recording, coil setup and outcome tracking into one workflow. It helps clinicians organize information, review reference-based options and document decisions throughout a treatment course.
Intended use
For trained clinicians working within their professional scope and local governance. Use the full pathway or an individual tool for assessment, placement support, recording and follow-up. Confirm outputs against patient findings, original sources and device instructions before use in care.
Clinician-operated decision support. Not intended for patient self-treatment.
Six connected tools
Use the tools sequentially or independently. Adapt the sequence to the patient and protocol; earlier steps are not required to open a tool.
- Assessment and planningReview the indication, history, safety and guideline-linked treatment options.
- Scalp locatorCalculate and review scalp markings using EEG 10–20, EEG 10–10 or Beam F3.
- Motor thresholdRecord responses with RR CTDS or ML-PEST CTDS, or document an external result.
- Coil setupDocument the machine, coil, measured reference, target and orientation.
- After-session reviewCompare pre-session and post-session symptoms and record clinical review.
- Treatment and follow-upTrack baseline and weekly ratings, review trends and export course reports.
Device-specific pathways may proceed directly from assessment to motor threshold. Neuronavigation and manufacturer instructions take precedence where applicable.
Explore the tools →Evidence and evaluation
Reference sources, software testing and clinician feedback inform different aspects of CTDS.
Technical and simulation testing
ML-PEST CTDS has undergone synthetic testing. The linked report provides methods, results and limitations.
ML-PEST simulation study →Clinical validation status
CTDS has not been validated as a clinical decision rule. Independent clinical validation of ML-PEST CTDS is pending. Clinicians must independently verify outputs before treatment.
Clinician feedback
Three psychiatrists who use rTMS clinically reviewed workflow and clarity.
EARLY USABILITY REVIEWWhat reviewers reported
3 psychiatrists27 October 2026Reviewers’ rTMS experience spans clinical practice, observation and patient referral.
Strongly agreeAgreeNeutralDisagree
Routine workflow
24 ratings · 8 items × 3 reviewers7 strongly agree17 agree0 neutral0 disagree
Caution workflow
15 ratings · 5 items × 3 reviewers1 strongly agree12 agree0 neutral2 disagree
Sample-report review
144 ratings · 48 items × 3 reviewers21 strongly agree120 agree3 neutral0 disagree
Overall workflow
6 ratings · 2 items × 3 reviewers3 strongly agree3 agree0 neutral0 disagree
Bar widths show the distribution within each section; numbers are individual item ratings. The same three reviewers contributed throughout, so these are not independent participant counts. No strongly-disagree responses were recorded. Preliminary usability feedback does not establish clinical validation.
Responsible clinical use
Disclaimers and safety
Clinical judgment, informed consent and device-specific procedures guide every stage.
Review before use
Automated history highlights may be incomplete. CTDS does not diagnose, prescribe, control a stimulator or provide clearance to treat. A completed form or green result does not establish safety or accuracy. Independently confirm MT estimates before treatment.
Clinical responsibility and evidence
The treating clinician remains responsible for the indication, risk–benefit assessment, informed consent, protocol and final decision. Reports support documentation and physician review.
Evidence strength varies by indication and method. Software adaptations and synthetic testing do not establish clinical effectiveness, regulatory clearance or equivalence to another application.
Consult original sources and current device labeling. Reference inclusion does not imply endorsement by authors, manufacturers or professional organisations.
Screening, monitoring and safety
Screening is not clearance. A negative screen or empty flag list does not establish eligibility. Complete patient-specific TMS screening, including relevant implants, seizure history, medical conditions, medications, substance use and changes since the last assessment. Resolve concerns before proceeding.
Follow device-specific instructions, appropriate hearing protection, trained supervision and your service’s monitoring and emergency procedures. Review new symptoms, adverse effects or changes in clinical state before continuing.
Do not rely on a screening score or automated flag alone to exclude risk or manage an urgent concern. Use the appropriate clinical assessment and local escalation pathway.
TMS safety reference: Rossi et al. (2021) ↗Privacy and temporary records
Draft entries are held temporarily in this browser tab. Avoid patient identifiers, copy or export any report you need to retain, and clear the assessment when finished.
Earlier entries remain available while moving between tools in the same tab. Review them before reuse. CTDS does not replace your clinical record.
Clinician workflow review
Test a fictional case
No sign-in, subscription or payment is needed. Use the supplied fictional cases only; do not enter identifiable patient information.
- For hands-on cases, select New assessment to start with empty entries. Enter only the information supplied; leave unknown findings unanswered.
- Move between the six tools in the same browser tab. Open any tool directly when earlier steps are not relevant.
- Review and copy or download the report before starting the next case. Record feedback in the review form. For report-only cases, review the supplied outputs without rerunning them.
Entries are temporary and are not saved to an account. Export what you need before closing the tab. This exercise evaluates workflow and software output; it is not treatment clearance.